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Edited by Shou-Wei DingAbstract CpG-methylation blocks the activity of RNA poly-
merase II transcribed promoters in most cases. In contrast, the
role of DNA methylation in the regulation of RNA polymerase
III transcribed promoters is less clariﬁed. There are two untrans-
lated viral RNAs (EBER-1 and EBER-2) in most malignant cells
carrying latent Epstein-Barr virus (EBV) genomes. We found
that in vitro methylation blocked binding of the cellular proteins
c-Myc and ATF to the 5 0-region of the EBER-1 gene, and
silenced the expression of the EBER-1 and EBER-2 genes, tran-
scribed by RNA polymerase III, in transfected cells.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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binding1. Introduction
Epstein-Barr virus (EBV) is associated with a series of
human neoplasms. Depending on the activity of the latent
promoters, diﬀerent sets of EBV-encoded nuclear antigens
and membrane proteins are expressed in the phenotypically
diﬀerent host cells [1]. EBV also encodes, however, two
untranslated RNAs (EBER-1 and EBER-2) that are expressed
constitutively, independently of the cellular phenotype [2–7].
The EBER genes are transcribed by RNA polymerase III
(Pol III) and contain intragenic Pol III control regions. They
are associated, however, with upstream elements of typical
RNA polymerase II (Pol II) promoters, too [5,8]. In lymphoid
cells binding of nuclear proteins to the 5 0-ﬂanking sequences of
the EBER genes was demonstrated by in vivo footprinting [9].
EBERs may contribute to oncogenic cell transformation by
blocking apoptosis or enhancing autocrine growth factor pro-
duction (reviewed in Ref. [10]). In order to elucidate the mech-
anisms regulating EBER expression, we assessed the potential
regulatory role of CpG-methylation by analysing the expres-
sion of an in vitro methylated EBER construct introduced into
EBV-negative cells and studied the occupancy of transcription*Corresponding author. Fax: +36 1 394 5409.
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doi:10.1016/j.febslet.2008.01.042factor binding sites in unmethylated and CpG-methylated
EBER-1 promoters.2. Materials and methods
2.1. Cell lines
The EBV negative Burkitts lymhoma (BL) line DG75 and the cervix
carcinoma cell line HeLa were maintained in RPMI 1640 medium con-
taining 10% fetal calf serum at 5% CO2 and 37 C.
2.2. Construction of pBS-EBER, in vitro methylation, transfection and
expression of the EBER-1 and EBER-2 genes
A PCR fragment carrying both EBER genes was generated by ampli-
fying DNA isolated from the marmoset cell line B95-8 using the primers
gcgtgaattcccataaagcccagggtgtaaaac and ggtgaattccccttacatgttgtgggtg-
caaaac (corresponding to nucleotides 6456–6478 and 7162–7138 of
the B95-8 EBV genome [11] and ﬂanked by the recognition sequence
of EcoRI; underlined). The fragment was cut with EcoRI, and ligated
into the EcoRI site of pBS-, yielding pBS-EBER. 20 lg of pBS-EBER
DNA was methylated (or mock-methylated) using MSssI CpG methyl-
transferase (New England Biolabs) as advised by the manufacturer. The
eﬃciency of methylation was conﬁrmed using the isoschisomers HpaII
and MspI as described [12]. Methylated and mock-methylated pBS-
EBER (9 lg, each) was cotransfected with 1 lg of the plasmid pEGFP
(encoding GFP, green ﬂuorescent protein; BD Biosciences) into 5 · 106
DG75 cells using DEAE dextrane (as described in Ref. [26]) or 3 · 105
HeLa cells (using Fugene reagent; Roche). DNA and RNAwas isolated
from the cells using TRI-reagent (Sigma) 48 h after transfection. The
isolated DNA was analysed for CpG-methylation (see below). EBER-
1 and EBER-2 RNA levels and expression of the cotransfected GFP
gene and the cellular b-actin gene were analysed on a LightCycler 2.0
instrument (Roche) by real-time quantitative PCR. First-strand cDNA
was synthesized using 1 lg RNA and 2 pmol primer (see Table 1) with
the SuperScript II system (Invitrogen) as suggested by the manufac-
turer. Ampliﬁcation was performed with primers described in Table 1
using a LightCycler FastStart Master SYBR Green kit (Roche),
according to the manufacturers protocol. The relative level of EBERs
was calculated after correcting for GFP and b-actin expression levels.
2.3. High resolution analysis of CpG-methylation at the EBER locus
DNA samples isolated from pBS-EBER transfected DG75 and
HeLa cells were bisulﬁte-modiﬁed, PCR-ampliﬁed (see Table 1) and se-
quenced as in our earlier studies [13,14].
2.4. Analysis of protein–DNA interactions at the unmethylated versus
methylated EBER-1 transcription unit
Control mock-methylated and CpG-methylated pBS-EBER was cut
with the restriction endonuclease EcoRI. A 0.7 kb EcoRI–EcoRI frag-
ment carrying both EBER genes was gel puriﬁed and 5 0-end labeled
using [c-32P] ATP, cut with PvuII, and a gel-puriﬁed EcoRI–PvuII
fragment (324 bp) was digested with RNase-free DNase I using a Core
Footprinting System (Promega), as suggested by the manufacturer.blished by Elsevier B.V. All rights reserved.
Table 1
Primers and PCR conditions used in this study
Position of primer Sequence
A
1. (7051–7033) 50-BIO-ACCTCTCTTCTCCTCCCCC-30
2. (6758–6783) 50-UNI-GTTTTYGGTTAAGTATTAGTTGGTGG-30
B
14. (6785–6770) 50-GAC CAC CAG CTG GTA C-30
15. (7119–7104) 50-GGA CAA GCC GAA TAC C-30
16. (1227–1207) 50-TGT AAC GCA ACT AAG TCA TAG-30
17. (1004–987) 50-TTG TAC AGC TCG TCC ATG-30
18. (6656–6676) 50-CTA GGG AGG AGA CGT GTG TGG-30
19. (6777–6757) 50-GCT GGT ACT TGA CCG AGG ACG-30
20. (6988–7004) 50-ACC GCC ACG CTC AGT G-30
21. (7111–7091) 50-CGA ATA CCC TTC TCC CAG AGG-30
22. (974–994) 50-GGC GGC ACC ACC ATG TAC CCT-30
23. (1175–1155) 50-AGG GGC CGG ACT CGT CAT ACT-30
24. (760–780) 50-CAG AAG AAC GGC ATC AAG GTG-30
25. (942–924) 50-GTG ATC GCG CTT CTC GTT G-3 0
C
Primer pairs PCR conditions Cycle number
1–2 95 C 4000 65 C 4000 72 C 6000 32
18–19, 20–21, 22–23, 24–25 95 C 500 62 C 500 72 C 800 45
A: primers used for the ampliﬁcation of a region of the EBER locus [11] from bisulﬁte-modiﬁed DNA samples. BIO stands for biotin, UNI designates
15 bases of M13 universal primer. B: primers used for reverse transcription of EBER-1 (14), EBER-2 (15), b-actin mRNA (16; EMBL/GeneBank
Acc. No.: NM_001101), and GFP mRNA (17; EMBL/GeneBank Acc. No.: U76561) and primer pairs used for ampliﬁcation of corresponding
cDNA sequences (18–19, 20–21, 22–23 and 24–25), respectively. C: The PCR conditions used.
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binding sequences
Electrophoretic Mobility Shift Assay (EMSA) was performed as de-
scribed [9], using nuclear extract from Mutu-BL-I-Cl-216 cells and the
following [c-32ATP]-labeled, blunt ended, double stranded, unmethy-
lated or CpG-methylated oligonucleotide (Metabion, Germany), har-
bouring the ATF binding site located upstream from the EBER-1
gene (ATF-box-oligo, nucleotides 6568–6599 of the B95-8 EBV gen-
ome [11], only one strand displayed):
5 0-cccgtcacggtgacgtagtctgtcttgaggag-3 0. Unlabeled ATF-box-oligo
was used as a speciﬁc competitor and a 218 bp long unrelated sequence
(a PCR product corresponding to nucleotides 169372–169590 of the
B95-8 EBV genome [11]) was used as a non-speciﬁc competitor.3. Results
3.1. In vitro DNA methylation silences the EBER promoters
Because the EBER locus is invariably hypomethylated in the
cell lines analysed [7], we assessed the eﬀect of CpG-methyla-
tion on EBER-1 and EBER-2 expression by introducing an
in vitro methylated plasmid (pBS-EBER), carrying both EBER
genes, into EBV-negative cells. The MSssI-methylated EBER
locus remained fully methylated 48 h after transfection
(Fig. 1a and data not shown). CpG-methylation suppressed
both EBER-1 and EBER-2 expression in DG75 (data not
shown) and HeLa cells (Fig. 1b) in 4 independent experiments.3.2. CpG-methylation blocks binding of nuclear proteins c-Myc
and ATF to the 5 0 regulatory region of the EBER-1
transcription unit in vitro
We used an in vitro DNase I footprinting assay to compare
transcription factor occupancy at the regulatory sequences of
the CpG-methylated and unmethylated EBER-1 gene. We
found that a DNase I footprint present at the unmethylated
binding site of c-Myc (visualized as bands of reduced intensity
of the protein-bound sample, compared to the protein minussamples) is absent from the CpG-methylated DNA (Fig. 2a).
Minor diﬀerences between the protein-bound unmethylated
and methylated DNAs could also be observed between the c-
Myc binding site and the promoter distal Sp1 binding site,
and within both Sp1 sites. The intensity of several bands was
reduced at the ATF binding site of the unmethylated, protein
bound sample, but not in the corresponding region of the
CpG-methylated DNA. In contrast, a strong enhancement of
band intensity could be observed at the TATA box both at
the unmethylated and at the CpG-methylated EBER-1 pro-
moter. There were minor diﬀerences between the footprint pat-
terns of unmethylated and CpG-methylated samples within the
intragenic Pol III control regions (Boxes A and B) as well.
The binding of nuclear proteins to the ATF binding site
located upstream of the EBER-1 gene was also analysed using
EMSA (Fig. 2b). We found that a nuclear extract of Mutu-
BL-I-Cl-216 cells yielded sequence-speciﬁc nucleoprotein
complexes with unmethylated, but not with CpG-methylated
ATF-box-oligo.4. Discussion
Eukaryotes are unique in using three separate RNA poly-
merase functions for the transcription of nuclear genes [15].
A huge variety of protein coding genes are transcribed by
Pol II whereas Pol I and Pol III transcribe a limited set of pro-
tein non-coding genes (reviewed in Ref. [16]). DNA methyla-
tion is an important regulator of Pol II promoters in
vertebrates [17], and most of the data support that cytosine-
methylation aﬀects the activity of Pol III promoters, too [18–
21]. We found that DNA methylation suppresses both
EBER-1 and EBER-2 transcription and blocks methylation
sensitive DNA binding of the cellular proteins c-Myc and
ATF [22,23] in the 5 0-region of EBER-1. We also observed
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Fig. 1. CpG-methylation suppresses the activity of EBER-1 and EBER-2 promoters. pBS-EBER, a plasmid carrying cloned EBER-1 and EBER-2
transcription units was methylated at CpG dinucleotides using MSssI methyltransferase in vitro or mock-methylated and transfected into HeLa cells.
(A) Methylation analysis of the CpG-methylated and mock-methylated construct pBS-EBER 48 h after transfection. A region of the EBER locus
situated 5 0 from the EBER-2 transcription unit is shown (positions 6808–6885 of the B95-8 EBV genome, [11]). Due to bisulﬁte treatment, all of the
cytosines (C; blue) were converted to uracils and sequenced as T instead of C after PCR ampliﬁcation in the mock-methylated construct and outside
CpG-dinucleotides in the MSssI-methylated construct. In the MSssI-methylated pBS-EBER plasmid all cytosines located within CpG dinucleotides
resisted bisulﬁte modiﬁcation and appeared as cytosines in the ﬁnal genomic sequence. B: Relative level of EBER-1 and EBER-2 RNA in HeLa cells
48 h after transfection with mock-methylated control or MSssI-methylated pBS-EBER plasmid. The relative level of EBER-1 and EBER-2
expression was calculated after correcting for cotransfected green ﬂuorescent protein gene expression and endogenous b-actin RNA expression levels.
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nition sites located in the 5 0 region, and within the intragenic
Pol III control region of the CpG-methylated EBER-1 gene.Further studies are needed to elucidate the signiﬁcance of these
changes. Both EBERs are constitutively expressed in the major
EBV cell types [7]. This ubiquitous expression may be due to
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Fig. 2. In vitro DNase I footprinting and EMSA analysis of unmethylated and CpG-methylated EBER-1 locus. (A) arrows and arrowheads on the
right of the ﬁgure indicate diﬀerences in the DNase I footprints of protein-bound unmethylated and CpG-methylated samples. M: unmethylated
DNA; M+: CpG-methylated DNA. Numbers indicate nucleotide positions in the B95-8 EBV sequence [11]; an arrow on the left side shows the
transcriptional start site. (B) binding of proteins of Mutu-BL-I-Cl-216 cell nuclear extract to unmethylated and CpG-methylated ATF-box-oligo is
shown. Arrows: sequence-speciﬁc complexes. Triangle: unspeciﬁc complex. Lanes 1–4: unmethylated ATF-box-oligo; lanes 5–8, CpG-methylated
oligo. Lanes 1 and 5, probe only, no protein added; lanes 2–4 and 6–8: nuclear extract added. Lanes 3, 7: unlabeled non-speciﬁc competitor added;
Lanes 4, 8: unlabeled speciﬁc competitor added.
708 F. Banati et al. / FEBS Letters 582 (2008) 705–709the combination of Pol II and Pol III promoter elements [5,8]
and correlates with hypomethylation of the EBER locus [7]. In
addition, the intense band observed at the TATA box 5 0 from
the EBER-1 gene (Fig. 2a) suggests that Pol II and Pol III spe-
ciﬁc factors may cooperate in the unusually high expression of
EBER RNAs. In addition, Felton-Edkins et al. found that the
activity of EBER-1 and EBER-2 promoters is stimulated by a
hyperphosphorylated form of ATF2, and elevated levels of
TFIIIC (an RNA polymerase III-speciﬁc factor) and BDP1
(a subunit of TFIIIB) in EBV infected cells [24]. Thus, one
could speculate that the changes of the cellular transcription
machinery described above and binding of the tissue-non-spe-
ciﬁc transcription factors c-Myc, Sp1 and ATF to the 5 0-region
of the EBER-1 gene may contribute to a high level of EBER-1
expression. Direct binding of c-Myc to TFIIIB, a Pol III spe-
ciﬁc transcription factor [25], may also contribute to the tran-
scriptional activation of the EBER genes. Tight binding of
nuclear proteins and constitutive transcription may keep the
EBER locus methylation free even in BL and NPC cells that
carry otherwise highly methylated EBV episomes [7].
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